CSL511 Fibrinogen Concentrate

fibrinogen concentrate (human) · CSL Behring

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CSL511 Fibrinogen Concentrate, covering 2026-03-11 to 2026-03-11. Get the full timeline:

Most recent: Clinical Trial Update: Phase 3 Study of Fibrinogen Concentrate (CSL511) in Subjects With Pseudomyxoma Peritonei Undergoing Cytoreductive Surgery [Phase 3]

See pricing